No, tilt-table testing is NOT indicated for a 20-year-old with Mobitz II (second-degree type II) heart block.
Mobitz II heart block is an indication for permanent pacemaker implantation, not tilt-table testing. These are fundamentally different clinical entities that require completely different management approaches.
Why This Distinction Matters
Mobitz II Block is a Structural Conduction Disease
- Mobitz II block represents infranodal disease at the His-Purkinje system and carries risk of progression to complete heart block 1
- It is characterized by sudden non-conducted P waves with constant PR intervals before and after the block, without the gradual PR prolongation seen in Wenckebach 1
- This is a pacemaker indication, not a reflex-mediated phenomenon 1, 2
Tilt-Table Testing is for Reflex Syncope
According to the 2017 ACC/AHA/HRS guidelines, tilt-table testing is indicated for:
- Suspected vasovagal syncope (VVS) when diagnosis is unclear after initial evaluation 3
- Suspected delayed orthostatic hypotension when initial evaluation is not diagnostic 3
- Distinguishing convulsive syncope from epilepsy in selected patients 3
Critical Pitfall: AV Block During Tilt-Table Testing ≠ Mobitz II
When AV block occurs during tilt-table testing, this represents a completely different phenomenon:
- It is a vagally-mediated reflex response, not structural conduction disease 4, 5
- Always preceded by sinus rate deceleration 4, 5
- Occurs in young women (mean age 21 years) with good long-term prognosis 4
- Does NOT require pacemaker implantation 4
- The sinus rhythm during this reflex AV block is slow and unstable, unlike true Mobitz II 5
The Correct Clinical Approach
For your 20-year-old with documented Mobitz II:
Verify the diagnosis is truly Mobitz II - this is commonly overdiagnosed 1:
If confirmed as true Mobitz II: Proceed directly to permanent pacemaker evaluation, not tilt-table testing
If the diagnosis is uncertain: Consider electrophysiology study to determine the level of block, not tilt-table testing
The evidence is clear that tilt-table testing has no role in the evaluation or management of structural AV conduction disease like Mobitz II block 3, 4, 5.